Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Marie Skłodowska-Curie Action · Running

Implant-to-Market Initiatives to Accelerate the Translation of Research into Market-Ready Surgical Implantable Medical Devices by Strengthening Regulatory Science and Improved Regulatory Competencies Among Researchers

Coordinator
Institut National Polytechnique De Toulouse, France
Runs
1 March 2027 to 28 February 2031
Status
Running
EU funding
€4.6m
Total cost
—
Partners
20 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101311759

What the project is doing

In the project's own words, from its summary on CORDIS.

Implant-to-Market will be a Doctoral Network (combining training and research) composed of 15 academic partners and 5 industrial partners (large companies and SMEs), focused on accelerating the translation of research into market-ready surgical implantable medical devices. Despite major scientific advances, the medical device sector, particularly implantable devices for surgery, still faces slow innovation transfer due to fragmented regulatory knowledge, limited cross-talk between scientists and regulatory experts, and shortages of skilled personnel.

Training is therefore essential to reinforce innovation capacity and global competitiveness. A European doctoral network integrating training and research is the most relevant instrument to address these challenges. The training programme developed in this project will be sustained beyond the project, and the qualifications of doctoral candidates and early-career researchers will be established by the consortium using shared methodologies.

The research methodology will rely on multidisciplinary and cross-sectoral collaborations involving universities, hospitals and industry. The work packages will address key needs: (i) integrating scientific data into regulatory processes and improving regulatory understanding among researchers; (ii) assessing safety and performance of implantable medical devices; (iii) reducing animal testing through alternative methods; (iv) developing multi-personalized and advanced medical devices; and (v) implementing sustainable-by-design strategies.

Expected outcomes include improved regulatory-science practices, enhanced qualification pathways, accelerated translation of innovations, and stronger interaction between research, clinics, regulation and industry. implant-to-market will help bridge the gap between scientific discovery and clinical adoption worldwide.

Who is involved

OrganisationCityCountryRole
Institut National Polytechnique De ToulouseToulouse Cedex 4FranceCoordinator
CerhumLiegeBelgiumParticipant
Universite De LiegeLiegeBelgiumParticipant
Dr. H. C. Robert Mathys Stiftung Fur Forschung, Dienstleistung, Technologietransfer Und Die Ausbildungsforderung in Der Medizinal - Und WerkstofftechnikBettlachSwitzerlandParticipant
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandAssociatedpartner
Eidgenossische Materialprufungs- Und ForschungsanstaltDubendorfSwitzerlandParticipant
Lipal Biochemicals SAGundetswilSwitzerlandAssociatedpartner
Universitaet BernBernSwitzerlandAssociatedpartner
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Universidad Politecnica De MadridMadridSpainParticipant
3deus Dynamics SASVilleurbanneFranceParticipant
Acm PharmaBellegardeFranceParticipant
Centre Hospitalier Universitaire De ToulouseToulouse Cedex 3FranceAssociatedpartner
Fondation Hopital Saint JosephParisFranceAssociatedpartner
Sofradim Production SasuTrevouxFranceParticipant
Universite De ToulouseToulouseFranceAssociatedpartner
Politecnico Di TorinoTorinoItalyAssociatedpartner
Universita Degli Studi Di PadovaPadovaItalyParticipant
Stichting Radboud UniversiteitNijmegenNetherlandsParticipant
Universidade Do PortoPortoPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI